Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05070143 · ClinicalTrials.gov registry record · NA
Mini-treatment Experiments to Clarify How to Assist People to Habit Formation
A NA study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- NA
- Development phase
- 286
- Enrollment target
NCT05070143: Completed NA study, sponsored by University of California, Berkeley.
NCT05070143 is a NA study that has completed, run by University of California, Berkeley. The registered enrollment target is 286 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05070143, a NA study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- NA
- Development phase
- 286 participants
- Enrollment target
Study Summary
Habits impact nearly every domain of one's physical and mental health. Evidence-based psychological treatments (EBPTs) are interventions targeting psychological processes that cause and/or maintain mental illness and that have been developed and evaluated scientifically. An implicit goal of EBPTs is to disrupt unwanted habits and develop desired habits. Yet, there has been insufficient attention given to habit formation principles, theory and measures in the development and delivery of EBTPs. In preparing to conduct a 5-year R01 on this topic, the investigators are conducting this experiment to better understand habit formation. The purpose is to distill, study and clarify key concepts in habit formation before embarking on the 5-year R01. This is necessary as there is surprisingly little research to guide key decisions, particularly for the process of dismantling unwanted habits. Hence, the aim of this experiment is to compare strategies discussed in the scientific literature, which have been minimally studied, to dismantle unwanted habits. The hypothesis tested is that each of the active strategies will be superior to the no intervention group. The study is exploratory as to which of the active strategies will be most effective.
Primary Outcome
Assesses perceived functional impairments related to sleep problems using a self-report questionnaire. The minimum value is 8. The maximum value is 40. Higher scores mean more sleep disturbance (worse outcome).
Interventions
- BEHAVIORAL Implementation Intentions
- BEHAVIORAL RISE-UP Routine
- BEHAVIORAL Awareness Training
- BEHAVIORAL Vigilant Monitoring
- BEHAVIORAL Values-based Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
What the finished NCT05070143 record still lists
NCT05070143 is an interventional study that assigns participants to a tested intervention. The registered 286 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 5 interventions - of which Implementation Intentions is the first listed.
NCT05070143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05070143 about?
NCT05070143 is a clinical study titled "Mini-treatment Experiments to Clarify How to Assist People to Habit Formation". Habits impact nearly every domain of one's physical and mental health. Evidence-based psychological treatments (EBPTs) are interventions targeting psychological processes that cause and/or maintain mental illness and that have been developed and evaluated scientifically. An implicit goal of EBPTs is...
What is the current status of trial NCT05070143?
This trial is currently completed. It is a NA study. The enrollment target is 286 participants. The study started on 2021-10-07. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT05070143?
The interventions under investigation include: Implementation Intentions (BEHAVIORAL), RISE-UP Routine (BEHAVIORAL), Awareness Training (BEHAVIORAL), Vigilant Monitoring (BEHAVIORAL), Values-based Approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT05070143?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05070143's enrollment target sits among peer trials
286 377th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04781140 · 286 participants · Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- NCT04936529 · 286 participants · Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- NCT05183646 · 286 participants · Phase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- NCT05506878 · 286 participants · NA
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI